Evaluation for topical use of ripasudil as ophthalmic solution.
Not Applicable
- Conditions
- Glaucoma
- Registration Number
- JPRN-UMIN000046037
- Lead Sponsor
- Kawasaki Medical School
- Brief Summary
The mean endothelial cell density loss 90 to 120 days after surgery, excluding bullous keratopathy patients for whom measurements were not possible was -4.5% in the ripasudil group, which was significantly lower than in control group
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
With active ocular surface disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method